In Blow To LabCorp, Board Says DNA Sequencing Patent Is Nonobvious

Mealey's (December 13, 2022, 12:19 PM EST) -- ALEXANDRIA, Va. — In a Dec. 12 final written decision (FWD) the Patent Trial and Appeal Board confirmed the patentability a “rapid, non-invasive method for determining the sequence of DNA from a fetus” that can be used “for detection of chromosomal abnormalities.”...